State of New York
|
1-10113
|
11-0853640
|
(State of Other Jurisdiction
|
(Commission File Number)
|
(I.R.S. Employer
|
of Incorporation)
|
Identification Number)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
|
Item 8.01
|
Other Events
|
Exhibit Number
|
Description
|
|
99.1
|
|
Press Release dated October 3, 2011
|
ACURA PHARMACEUTICALS, INC.
|
||
By:
|
/s/ Peter A. Clemens
|
|
Peter A. Clemens
|
||
Senior Vice President & Chief Financial Officer
|
Exhibit Number
|
Description
|
|
99.1
|
|
Press Release dated October 3, 2011
|